Skip to content

DCA™ Systems Hemoglobin A1c Reagent Kit 10311134Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · DCA HbA1c Test Kit (monitoring only) - INTL. · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 7, 2024Class IIOpen, Classified

    The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the performance of these five HbA1c lots was compared to NGSP pooled patient target-value assigned samples and the maximum bias observed was 19%.

    Z-1304-2024 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Other ASSAY, GLYCOSYLATED HEMOGLOBIN devices

All ASSAY, GLYCOSYLATED HEMOGLOBIN devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page